TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells
Authors:
- 15 November 2016
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 56 (4) , 1302-1311
Abstract
Transforming growth factor β (TGFβ) is a multifunctional cytokine which is importantly implicated in hepatocarcinogenesis. The current study provides novel evidence that TGFβ upregulates the expression of multiple receptor tyrosine kinases (RTKs), including IGF1R, EGFR, PDGFβR, and FGFR1 in human hepatocellular carcinoma (HCC) cells. This, in turn, sensitized HCC cells to individual cognate RTK ligands, leading to cell survival. Our data showed that the TGFβ‐mediated increase in growth factor sensitivity led to evasion of apoptosis induced by the mutikinase inhibitor, sorafenib. Conversely, we observed that inhibition of the TGFβ signaling pathway by LY2157299, a TGFβRI kinase inhibitor, enhanced sorafenib‐induced apoptosis, in vitro. Our findings disclose an important interplay between TGFβ and RTK signaling pathways, which is critical for hepatocellular cancer cell survival and resistance to therapy.Keywords
Funding Information
- National Institutes of Health (DK077776, CA102325)
This publication has 48 references indexed in Scilit:
- Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell LinesPLOS ONE, 2013
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentHepatology, 2012
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- RNA-Seq gene expression estimation with read mapping uncertaintyBioinformatics, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancerHepatology, 2008
- PDGF essentially links TGF-β signaling to nuclear β-catenin accumulation in hepatocellular carcinoma progressionOncogene, 2006
- PI3K/Akt and apoptosis: size mattersOncogene, 2003